This paper proposes an exploratory characterisation of firms’ patenting behaviours across 15 countries. The stylised facts proposed are meant to serve as a basis for broader policy relevant analyses, and as a starting point for a more informed discussion on the role of country-specific framework conditions in explaining the observed differences in firm behaviours and outcomes.
Knowledge networks and markets comprise the wide array of mechanisms and institutions facilitating the creation, exchange, dissemination and utilisation of knowledge in its multiple forms. This report provides new evidence on the knowledge-sourcing strategies of firms and their role in shaping innovation activities, according to different characteristics, and their impact on performance.
The aim of this consultation, held on 20-21 June 2013 in Oxford (UK), was to stimulate discussion at the highest possible level of expert engagement in setting out an agenda for OECD action to accelerate innovation for Alzheimer’s disease and dementia.
KNMs are arrangements which govern the transfer of various types of knowledge, such as intellectual property, know-how, software code or databases, between independent parties across the economy. The OECD's KNM project studies existing and emerging knowledge allocation mechanisms and their impact on knowledge creation, dissemination and use. The assessment of the economic significance of KNMs informs an evidence-based approach to
This review provides a quantitative and qualitative assessment of countries’ capacity in S&T and innovation. A regional synthesis highlights current performance and knowledge circulation, and country profiles describe the dynamics of national innovation systems and their relation to international knowledge flows, taking into account the wider framework conditions for innovation.
This book evaluates the performance of the knowledge-based sector in Mexico and provides policy recommendations for improving the financing, creation and expansion of innovative knowledge-based start-ups.
This framework introduces a risk-based oversight and management methodology for clinical trials. It combines a stratified approach that is based on the marketing authorisation status of the medical product and can be applied in a common manner across countries’ regulatory frameworks, with a trial-specific approach that considers other issues such as the type of populations concerned by the trial, or the informed consent of the patients.
English, PDF, 8,330kb
This report addresses a number of policy-relevant themes around innovation and inclusive development. It provided background reflection for a conference on the topic organised by the OECD and South Africa’s Department for Science and Technology on 21 November 2012 in Cape Town.